222 related articles for article (PubMed ID: 17554538)
1. Whole-body imaging of the musculoskeletal system: the value of MR imaging.
Schmidt GP; Reiser MF; Baur-Melnyk A
Skeletal Radiol; 2007 Dec; 36(12):1109-19. PubMed ID: 17554538
[TBL] [Abstract][Full Text] [Related]
2. Whole-body imaging of bone marrow.
Schmidt GP; Reiser MF; Baur-Melnyk A
Semin Musculoskelet Radiol; 2009 Jun; 13(2):120-33. PubMed ID: 19455475
[TBL] [Abstract][Full Text] [Related]
3. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
6. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.
Schmidt GP; Schoenberg SO; Schmid R; Stahl R; Tiling R; Becker CR; Reiser MF; Baur-Melnyk A
Eur Radiol; 2007 Apr; 17(4):939-49. PubMed ID: 16951929
[TBL] [Abstract][Full Text] [Related]
7. Whole-body MRI for the staging and follow-up of patients with metastasis.
Schmidt GP; Reiser MF; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
[TBL] [Abstract][Full Text] [Related]
8. [Whole-body MRI and FDG-PET/CT imaging diagnostics in oncology].
Schmidt GP; Haug A; Reiser MF; Rist C
Radiologe; 2010 Apr; 50(4):329-38. PubMed ID: 20229091
[TBL] [Abstract][Full Text] [Related]
9. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
[TBL] [Abstract][Full Text] [Related]
10. CT and MRI evaluation of musculoskeletal infection.
Ma LD; Frassica FJ; Bluemke DA; Fishman EK
Crit Rev Diagn Imaging; 1997 Dec; 38(6):535-68. PubMed ID: 9442978
[TBL] [Abstract][Full Text] [Related]
11. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
Zamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; Cangini D; Perrone G; Ceccolini M; Brioli A; Buttignol S; Fanin R; Salizzoni E; Baccarani M; Fanti S; Cavo M
Haematologica; 2007 Jan; 92(1):50-5. PubMed ID: 17229635
[TBL] [Abstract][Full Text] [Related]
12. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
[TBL] [Abstract][Full Text] [Related]
13. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
14. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
15. Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours.
Kembhavi SA; Rangarajan V; Shah S; Qureshi S; Arora B; Juvekar S; Laskar S; Vora T; Chinnaswamy G; Ramadwar M; Kurkure P
Clin Radiol; 2014 Sep; 69(9):900-8. PubMed ID: 24863003
[TBL] [Abstract][Full Text] [Related]
16. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities of whole-body MRI for investigating musculoskeletal diseases].
Lenk S; Fischer S; Kötter I; Claussen CD; Schlemmer HP
Radiologe; 2004 Sep; 44(9):844-53. PubMed ID: 15349730
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
19. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
[TBL] [Abstract][Full Text] [Related]
20. Whole-body PET/MRI: the effect of bone attenuation during MR-based attenuation correction in oncology imaging.
Aznar MC; Sersar R; Saabye J; Ladefoged CN; Andersen FL; Rasmussen JH; Löfgren J; Beyer T
Eur J Radiol; 2014 Jul; 83(7):1177-1183. PubMed ID: 24780817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
